| Cost-effectiveness analysis of prostaglandin E2 gel for the induction of labour at term. | |
| | |
MedLine Citation:
|
PMID: 21332635 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Please cite this paper as: Petrou S, Taher S, Abangma G, Eddama O, Bennett P. Cost-effectiveness analysis of prostaglandin E2 gel for the induction of labour at term. BJOG 2011; DOI: 10.1111/j.1471-0528.2011.02902.x. Objective To estimate the cost-effectiveness of prostaglandin E2 (dinoprostone) vaginal gel for the induction of labour at term from the perspective of the UK's National Health Service. Design Economic evaluation conducted as part of a randomised controlled trial. Setting Maternity department at a major teaching hospital in London, UK. Population A cohort of 165 pregnant women presenting as cephalic between 36(+6) and 41(+6) weeks of gestation, for whom induction of labour was deemed necessary. Methods Either 3-mg Prostin E2 vaginal tablets or 1- or 2-mg Prostin E2 vaginal gel were administered at 6-hourly intervals. Main outcome measures Incremental cost per hour prevented between induction and delivery. The nonparametric bootstrap method was used to construct cost-effectiveness acceptability curves and estimate net benefits at alternative cost-effectiveness thresholds. Results Women receiving the gel accrued nonsignificantly higher costs (incremental cost £630; bootstrap 95% CI -£353, £2320; P = 0.43), and experienced a significantly reduced interval between induction and delivery (median of 1400 versus 1780 minutes; mean of 1711 versus 2765 minutes; P = 0.03). The incremental cost per hour prevented from induction of labour to delivery was estimated at £36. At a cost-effectiveness threshold of £100 per hour of care prevented, the probability that the gel is cost-effective was estimated at 0.83, and the mean net benefit to the health services was estimated at £1121 (bootstrap 95% CI -£1133, £3379). The results were sensitive to the inclusion of neonatal costs in the analysis and the value of the cost-effectiveness threshold. Notably, excluding neonatal costs increased the probability that the gel is cost-effective at a cost-effectiveness threshold of £100 per hour of care prevented to 0.99. Conclusions This study suggests that prostaglandin E2 gel is probably more cost-effective than prostaglandin E2 tablets for the induction of labour at term. Given that the results are applicable to the general obstetric population requiring induction of labour at term, decision-makers should consider the likely economic impacts of their implementation. |
| | |
Authors:
|
S Petrou; Se Taher; G Abangma; O Eddama; P Bennett |
Related Documents
:
|
10703335 - Dealing with emotional outbreaks of alzheimer's clients on a special unit. 17395365 - Environmental education for small- and medium-sized enterprises: methodology and e-lear... 12839415 - Three basic principles of success. 8054165 - Maintenance and rehabilitation of independence in old age: an intervention program for ... 19969355 - Evaluation of the virtual mentor cataract training program. 16242035 - An online survey of chiropractors' opinions of continuing education. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-2-18 |
Journal Detail:
|
Title: BJOG : an international journal of obstetrics and gynaecology Volume: - ISSN: 1471-0528 ISO Abbreviation: - Publication Date: 2011 Feb |
Date Detail:
|
Created Date: 2011-2-21 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100935741 Medline TA: BJOG Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Copyright Information:
|
© 2011 The Authors BJOG An International Journal of Obstetrics and Gynaecology © 2011 RCOG. |
Affiliation:
|
Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK Department of Obstetrics and Gynaecology, Queen Charlotte's and Chelsea Hospital, Imperial College, London, UK Health Economics Research Centre National Perinatal Epidemiology Unit, Department of Public Health, University of Oxford, Headington, Oxford, UK. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Introduction of a single visit protocol in the management of selected patients with pregnancy of unk...
Next Document: Prediction of macrosomia at birth in type-1 and 2 diabetic pregnancies with biomarkers of early plac...